OliX Pharmaceuticals, Inc (KOSDAQ:226950)
180,000
+20,600 (12.92%)
Feb 27, 2026, 3:30 PM KST
223.74% (1Y)
| Market Cap | 3.63T |
| Revenue (ttm) | 10.18B |
| Net Income (ttm) | -43.30B |
| Shares Out | 20.19M |
| EPS (ttm) | -2,280.15 |
| PE Ratio | n/a |
| Forward PE | 330.38 |
| Dividend | n/a |
| Ex-Dividend Date | n/a |
| Volume | 816,375 |
| Average Volume | 400,913 |
| Open | 160,900 |
| Previous Close | 159,400 |
| Day's Range | 160,400 - 185,500 |
| 52-Week Range | 34,500 - 185,500 |
| Beta | 0.55 |
| RSI | 71.05 |
| Earnings Date | Mar 20, 2026 |